Weight-Loss Program Aids Black Breast Cancer Survivors

This article originally appeared here.
Share this content:
Weight-Loss Program Aids Black Breast Cancer Survivors
Weight-Loss Program Aids Black Breast Cancer Survivors

WEDNESDAY, June 21, 2017 (HealthDay News) -- A community-based interventionist-guided weight-loss program is efficacious for early-stage African-American breast cancer survivors (AABCS), according to a study published online June 15 in the Journal of Clinical Oncology.

Melinda Stolley, Ph.D., from the Medical College of Wisconsin Cancer Center in Milwaukee, and colleagues examined the effect of a weight loss intervention for AABCS on weight, body composition, and behavior. Early-stage AABCS were randomized to a six-month interventionist-guided or self-guided weight loss program (125 and 121 participants, respectively), which supported changes to promote a 5 percent weight loss. At baseline, post-intervention (six months), and follow-up (12 months), the authors collected anthropometric, body composition, and behavioral data.

The researchers found that both groups lost weight; the mean and percentage of weight loss were greater in the guided group compared with the self-guided group (six months: 3.5 versus 1.3 kg and 3.6 versus 1.4 percent, respectively; both P < 0.001; 12 months: 2.7 versus 1.6 kg and 2.6 versus 1.6 percent, respectively; both P < 0.05). Overall, 44 and 19 percent of participants in the guided and self-guided groups met the goal of 5 percent weight loss. At both time points, the interventionist-guided group had greater body composition and behavioral changes.

"Affordable, accessible health promotion programs represent a critical resource for AABCS," the authors write.

One author disclosed ties to Watermark Research Partners.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »